Linked Life Data

21696934

Source:http://linkedlifedata.com/resource/pubmed/id/21696934

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2011-7-18
pubmed:abstractText
COPD is associated with increased arterial stiffness which may in part explain the cardiovascular morbidity observed in the disease. A causal relationship between arterial stiffness and cardiovascular events has not been established, though their strong association raises the possibility that therapies that reduce arterial stiffness may improve cardiovascular outcomes. Prior studies suggest that fluticasone propionate/salmeterol (FSC) may improve cardiovascular outcomes in COPD and we hypothesized that FSC would reduce arterial stiffness in these patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1532-3064
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1322-30
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD.
pubmed:affiliation
University of Alabama Birmingham Lung Health Center, University of Alabama at Birmingham, The Birmingham VA Medical Center, Birmingham, AL, USA. mdransfield99@msn.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study